To summarize the literature and provide preliminary evidence-based treatment guidelines for pediatricians and neurologists, we performed a comprehensive literature search and examined the efficacy of mTOR inhibitor therapy and the possible adverse effects in 129 pediatric patients with TSC. The gene discussed is MTOR; the disease is tuberous sclerosis.